Fertility and gynaecologic malignancies

Journal of Obstetrics and Gynaecology Research

Volumn 27, Issue 1, 2001, Pages 1-15

  Sivanesaratnam, V ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Chemotherapy; Contraception; Fertility; Gynaecologic cancer; Pregnancy; Surgery

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRACEPTIVE AGENT;

AMENORRHEA; BRAIN METASTASIS; BREAST CANCER; BREAST FEEDING; CANCER INVASION; CANCER RISK; CANCER SURVIVAL; CHORIOCARCINOMA; CONTRACEPTION; EARLY DIAGNOSIS; ENDOMETRIUM CANCER; FAMILIAL CANCER; FEMALE; FERTILITY; GYNECOLOGIC CANCER; GYNECOLOGIC SURGERY; HIGH RISK PATIENT; HIGH RISK PREGNANCY; HUMAN; HYDATIDIFORM MOLE; OVARY CANCER; PELVIS LYMPHADENECTOMY; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; RECURRENT DISEASE; REVIEW; SQUAMOUS CELL CARCINOMA; TERATOGENICITY; UTERINE CERVIX CARCINOMA; UTERINE TUBE LIGATION;

EID: 0035085058     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2001.tb01208.x     Document Type: Review

References (151)

1. Oral contraceptives and breast cancer risk among younger women
2. Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53, 297 women with breast cancer and 100, 239 women without breast cancer from 54 epidemiological studies
3. Incessant ovulation - A factor in ovarian neoplasia?
4. Epidemiology and biostatistics
5. Determinants of ovarian cancer risk. I. Reproductive experience and family history
6. Cancer incidence and mortality in women receiving oestrogen and oestrogen-progestin replacement therapy - Long term follow-up of a Swedish Cohort
7. Serum gonadotrophins and steroid hormones and development of ovarian cancer
8. Oral contraceptives and risk of ovarian cancer
9. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer. III. Oral contraceptive use
10. On the epidemiology of oral contraceptives and disease
11. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relations to changing fertility and oral contraceptive use
12. The molecular genetics of sporadic and familial epithelial ovarian cancer
13. Oral contraceptives and the risk hereditory ovarian cancer
14. Oestrogen's role in endometrial cancer
15. Progestin therapy in endometrial hyperplasia
16. The biologic significance of cytologic atypia in progestin-treated endometrial hyperplasia
17. Centres for disease control cancer and steroid hormone study. Oral contraceptive use and risk of endometrial cancer
18. Adenocarcinoma of the endometrium in women taking sequential oral contraceptives
19. Invasive squamous cell carcinoma and combined oral contraceptives: Results from a multinational study
20. Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives
21. Combined oral contraceptives and risk of cervical carcinoma in situ
22. Oral contraceptives and cervical cancer - Further findings from the Oxford family planning association contraceptive study
23. Association of oral contraceptive use and human papilloma viruses in invasive cervical cancers
24. WHO collaborative study of neoplasia and steroid contraceptives. Depot-medroxy progestrone acetate (DMPA) and risk of invasive squamous cell cervical cancer
25. Cervical carcinoma-in-situ and use of depo-medroxy-progesterone acetate (DMPA)
26. Choriocarcinoma
27. Five years' experience with chemotherapy of metastatic choriocarcinoma and related trophoblastic tumours in women
28. Relationship of oral contraception to development of trophoblastic tumor after evacuation of hydatidiform mole
29. Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the UK
30. Oral contraceptives and post-molar trophoblastic disease
31. Relationship of oral contraceptives and the intrauterine devices to the regression of concentrations of the beta subunit of human chorionic gonadotrophin and invasive complications after molar pregnancy
32. Risk for ovarian cancer
33. The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US casecontrol studies. II. Invasive epithelial ovarian cancers in white women
34. Risk factors for ovarian cancer: A case control study
35. Reproductive, genetic, and dietary risk factors for ovarian cancer
36. Determinants of ovarian cancer risk. 11 inference regarding pathogenesis
37. Parity, contraception infertility and the risk of epithelial ovarian cancer
38. Parity, age at first birth, and risk of ovarian cancer
39. The ovarian mesothelioma
40. Cosmetic talc and ovarian cancer
41. Ovarian cancer and talc; A case control study
42. Perineal exposure to talc and ovarian cancer risk
43. Ovarian tumors: Classification, histogenesis, aetiology
44. Tubal sterilisation, hysterectomy and decreased risk of ovarian cancer
45. Tubal ligation, hysterectomy and risk of ovarian cancer - A prospective study
46. Tubal ligation and fatal ovarian cancer in a large prospective cohort study
47. Mineral fibre exposure and the development of ovarian cancer
48. IUD use and carcinoma of the cervix
49. Uterine malignancies developing after long-term use of IUDs
50. Recognising malignancy in intrauterine contraceptive device users
51. Uterine malignancy developing after long-term use of IUCD. Additional report of 2 cases: Endometrial stromal sarcoma and leiomyosarcoma
52. Infertility, fertility drugs, and invasive ovarian cancer: A case-control study
53. The etiology and prevention of ovarian cancer
54. The epidemiology of ovarian cancer
55. Fertility drugs and breast and ovarian cancer
56. Ovarian tumors in a cohort of infertile women
57. Human menopausal gonadotrophin and risk of epithelial ovarian cancer
58. Fertility drugs and the risk of breast and ovarian cancers; Results of a long-term follow-up study
59. Breast and ovarian cancer incidence after infertility and in vitro fertilization
60. Cancer incidence in a cohort of infertile women
61. Risk of breast cancer in a cohort of infertile women
62. Reproductive technologies and risk of ovarian cancer
63. The feasibility of assessing women's perceptions of the risks and benefits of fertility drugs therapy in relation to ovarian cancer risk
64. Effects of alkalyting chemicals on reproductive capacity of adult female mice
65. Effect of cytotoxic therapy on sexuality and gonadal function
66. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease
67. Chemotherapy for GTD may increase incidence of second tumors and may cause premature menopause
68. Fertility in patients with gestational trophoblastic tumors treated with etoposide
69. Ovarian dysfunction in patients with gestational trophoblastic neoplasia treated with short intensive courses of etoposide (VP 16-213)
70. Malignant evulation with fatal outcome in a patient with partial hydatidiform mole
71. Asherman's syndrome successfully treated by insertion of a multiload copper 250 device
72. Pregnancy after cytotoxic chemotherapy for gestational trophoblastic tumors
73. Cerebral metastases from horiocarcinoma
74. Normal pregnancy after successful treatment of choriocarcinoma with cerebral metastases
75. Gestational trophoblastic disease in Malaysia and the Pacific Basin
76. Reproductive performance of patients with gestational trophoblastic disease in Hong Kong
77. Outcome of pregnancies occurring before completion of human chorionic gonadotrophin follow-up in patients with persistent gestational trophoblastic tumor
78. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome
79. Effect of early pregnancy on relapse rates in patients who have completed chemotherapy for gestational trophoblastic disease
80. Assessment of the contemporary management of germ cell malignancies of the ovary
81. Update on management malignant ovarian germ cell tumor
82. Cure of stage IV endodermal sinus tumor of the ovary with pulsed cyclophamide
83. Preserving fertility in patients with epithelial ovarian cancer: The role of conservative surgery in early stage disease
84. Conservative surgery for ovarian cancer and effect on fertility
85. Conservative surgery for stage 1 ovarian carcinoma in women of childbearing age
86. Outcome and reproductive function after conservative surgery for borderline ovarian tumors
87. Artificially induced endometrial cycles and establishment of pregnancies in the absence of ovaries
88. Donor eggs. Their application in modern reproductive technologies
89. The concept of uterine preservation with ovarian malignancies
90. The management of gestational trophoblastic disease in developing countries such as Malaysia
91. Arterio-venous malformations of the uterus
92. Pregnancy following successful embolisation of a uterine vascular malformation
93. Radical vaginal hysterectomy in the primary treatment of invasive cervical cancer
94. Pregnancies after radical trachelectomy for the treatment of early-stage cervical cancer
95. The management of cervical carcinoma. Surgical radicality. Is it necessary to remove the corpus uteri in all cases of early invasive cervical cancer treated surgically
96. Cervical cancer
97. Successful preservation of fertility subsequent to a complete pathological response of a squamous cell carcinoma of the uterine cervix treated with primary systemic chemotherapy
98. Successful pregnancy after radical surgery for diethylstilboesterol (DES)-related vaginal adenocarcinoma. Case report
99. Sarcoma botryoides of the cervix. Excision followed by adjuvant chemotherapy for preservation of reproductive function
100. Sarcinoma botryoides of the cervix treated with limited surgery and chemotherapy to preserve fertility
101. Sarcoma botryoides of the female genital tract
102. The influence of pregnancy on tumor growth
103. Carcinoma of the cervix in pregnancy
104. Gynaecologic cancer complicating pregnancy
105. Gynaecologic malignancies in pregnancy
106. Gestational carcinoma of the female breast
107. Cancer in pregnancy
108. Effect of pregnancy on prognosis for young women with breast cancer
109. Pregnancy influences breast cancer stage at diagnosis in women 30 years of age and younger
110. Prognosis of pregnancy-associated breast cancer
111. Survival of breast cancer patients during pregnancy or lactation
112. Breast cancer during pregnancy and lactation
113. Influence of pregnancy on the outcome of breast cancer: A case control study
114. Carcinoma of the breast associated with pregnancy
115. Breast cancer and pregnancy
116. Clinicopathologic characteristics and prognosis of breast-cancer patients associated with pregnancy and lactation. Analysis of case-control study in Japan
117. BRCA 1 mutations in a population-based sample of young women with breast cancer
118. Treatment of the breast tumors associated with pregnancy and lactation
119. Breast cancer during pregnancy
120. Breast cancer in pregnancy and lactation
121. Carcinoma of breast in pregnancy and lactation
122. The effect of pregnancy on the prognosis of carcinoma of the breast following radical mastectomy
123. Pregnancy after breast cancer. Results of a case-control study
124. The prognosis of patients who become pregnant after mastectomy for breast cancer
125. Maternal and fetal outcome after breast cancer and pregnancy
126. Cancer of the breast in pregnancy
127. Age as a prognostic factor in premenopausal breast carcinoma
128. Carcinoma of the cervix in associated with pregnancy
129. Surgical management of early invasive cancer of the cervix associated with pregnancy
130. Invasive carcinoma of the cervix associated with pregnancy. Correlation between patient age, advancement of cancer and gestation, and result of treatment
131. Cervical carcinoma in pregnancy
132. Carcinoma of the cervix and pregnancy
133. Carcinoma of the cervix and pregnancy
134. Pregnant women with cervical cancer should deliver by Caesarean
135. Carcinoma of the cervix associated with pregnancy
136. Cervical adeno-carcinoma: Tumour implantation in the eoisiotomy sites of two patients
137. Radiotherapeutic management of cervical cancer complicating pregnancy
138. Neo-adjuvant chemotherapy in the treatment of locally advanced cervical carcinoma in pregnancy: A report of two cases and review of issues specific to management of cervical carcinoma in pregnancy including planned delay of therapy
139. Ovarian tumors in pregnancy
140. Growth and malignancy of ovarian tumors in pregnancy
141. Ovarian tumors complicating pregnancy in Malaysian Study
142. Ovarian malignancy in pregnancy
143. Neoplastic diseases
144. Antineoplastic agents and pregnancy
145. The effects of cancer chemotherapeutic agents on the developing fetus
146. Acute leukemia during pregnancy. The Toronto Leukaemia Study group experience with longterm follow-up of children exposed in utero to chemotherapeutics agents
147. A case of trans-placental metastases of malignant melanoma from mother to fetus
148. Choriocarcinoma in mother and fetus